136 related articles for article (PubMed ID: 16023001)
1. Zoledronic acid improves femoral head sphericity in a rat model of perthes disease.
Little DG; McDonald M; Sharpe IT; Peat R; Williams P; McEvoy T
J Orthop Res; 2005 Jul; 23(4):862-8. PubMed ID: 16023001
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA
J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515
[TBL] [Abstract][Full Text] [Related]
3. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
4. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
Kim HK; Morgan-Bagley S; Kostenuik P
J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Amanat N; McDonald M; Godfrey C; Bilston L; Little D
J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
[TBL] [Abstract][Full Text] [Related]
7. [A histopathological study on the femoral head necrosis in spontaneously hypertensive rats (SHR)].
Omokawa S; Tamai S; Ohneda Y; Mizumoto S; Yamamoto S
Nihon Seikeigeka Gakkai Zasshi; 1992 Jan; 66(1):69-82. PubMed ID: 1548443
[TBL] [Abstract][Full Text] [Related]
8. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
Little DG; Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
[TBL] [Abstract][Full Text] [Related]
9. Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits.
Smith EJ; Little DG; Briody JN; McEvoy A; Smith NC; Eisman JA; Gardiner EM
J Bone Miner Res; 2005 Oct; 20(10):1731-41. PubMed ID: 16160731
[TBL] [Abstract][Full Text] [Related]
10. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
[TBL] [Abstract][Full Text] [Related]
11. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
Johannesen J; Briody J; McQuade M; Little DG; Cowell CT; Munns CF
Bone; 2009 Nov; 45(5):898-902. PubMed ID: 19446052
[TBL] [Abstract][Full Text] [Related]
12. Femoral head deformity in Catterall groups III and IV Legg-Calvé-Perthes disease: magnetic resonance image analysis in coronal and sagittal planes.
Cho TJ; Lee SH; Choi IH; Chung CY; Yoo WJ; Kim SJ
J Pediatr Orthop; 2002; 22(5):601-6. PubMed ID: 12198461
[TBL] [Abstract][Full Text] [Related]
13. Experimentally gained insight - based proposal apropos the treatment of osteonecrosis of the femoral head.
Boss JH; Misselevich I; Bejar J; Norman D; Zinman C; Reis DN
Med Hypotheses; 2004; 62(6):958-65. PubMed ID: 15142657
[TBL] [Abstract][Full Text] [Related]
14. [An animal model of Perthes disease and an experimental research of VEGF expression].
Li W; Fan Q; Ma B; Ren M; Li H; Gou Y; Qian J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):814-9. PubMed ID: 18681281
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis and ossification disturbance of the femoral head in spontaneously hypertensive rats.
Iwasaki K; Hirano T
Nihon Seikeigeka Gakkai Zasshi; 1988 Nov; 62(11):1003-10. PubMed ID: 3150422
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation.
D'Souza AB; Grigg AP; Szer J; Ebeling PR
Intern Med J; 2006 Sep; 36(9):600-3. PubMed ID: 16911552
[TBL] [Abstract][Full Text] [Related]
17. Novel three-dimensional MRI technique for study of cartilaginous hip surfaces in Legg-Calvé-Perthes disease.
Pienkowski D; Resig J; Talwalkar V; Tylkowski C
J Orthop Res; 2009 Aug; 27(8):981-8. PubMed ID: 19405084
[TBL] [Abstract][Full Text] [Related]
18. Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis.
Arrington SA; Damron TA; Mann KA; Allen MJ
J Surg Oncol; 2008 Mar; 97(3):284-90. PubMed ID: 18161868
[TBL] [Abstract][Full Text] [Related]
19. Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.
Cheng TL; Murphy CM; Cantrill LC; Mikulec K; Carpenter C; Schindeler A; Little DG
Int Orthop; 2014 Jul; 38(7):1527-33. PubMed ID: 24389948
[TBL] [Abstract][Full Text] [Related]
20. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: an experimental investigation in immature pigs.
Kim HK; Aruwajoye O; Du J; Kamiya N
J Bone Joint Surg Am; 2014 Sep; 96(18):1515-24. PubMed ID: 25232075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
